Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
Status:
Terminated
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter phase II trial designed to evaluate the safety and
activity of the combination of association of arsenic trioxide (ATO) and ascorbic acid in
patients with myelodysplastic syndromes
Phase:
Phase 2
Details
Lead Sponsor:
Fondazione Italiana Sindromi Mielodisplastiche Onlus Fondazione Italiana Sindromi Mielodisplastiche-ETS
Collaborator:
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte